Skip to main content
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Immunomodulators

These sections summarize data on corticosteroids, IL-6 inhibitors, JAK inhibitors, and other immunomodulators.

Immunomodulators Summary Recommendations

Recommendations for the use of immunomodulators in patients with COVID-19

Systemic Corticosteroids

Information on the use of anti-inflammatory drugs as treatment for COVID-19

Inhaled Corticosteroids

Information on COVID-19 studies that evaluated the use of inhaled corticosteroids

Interleukin-6 Inhibitors

Information on the use of IL-6 inhibitors as treatment for COVID-19

Janus Kinase Inhibitors

Information on the use of JAK inhibitors as treatment for COVID-19

Interleukin-1 Inhibitors

Information on COVID-19 studies that evaluated the use of IL-1 inhibitors

Vilobelimab

Information on COVID-19 studies that evaluated the use of vilobelimab

Table: Characteristics of Immunomodulators

Characteristics of immunomodulators evaluated in COVID-19 clinical trials